Bruker Stock Fundamentals
| BRKR Stock | USD 75.61 1.64 2.12% |
Bruker fundamentals help investors to digest information that contributes to Bruker's financial success or failures. It also enables traders to predict the movement of Bruker Stock. The fundamental analysis module provides a way to measure Bruker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bruker stock.
At this time, Bruker's Total Other Income Expense Net is relatively stable compared to the past year. As of 05/28/2024, Depreciation And Amortization is likely to grow to about 120.6 M, while Cost Of Revenue is likely to drop slightly above 737 M. Bruker | Select Account or Indicator |
Bruker Company Operating Margin Analysis
Bruker's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bruker Operating Margin | 0.11 % |
Most of Bruker's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bruker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Bruker Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Bruker has an Operating Margin of 0.11%. This is 100.31% lower than that of the Life Sciences Tools & Services sector and 100.28% lower than that of the Health Care industry. The operating margin for all United States stocks is 102.0% lower than that of the firm.
Bruker Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bruker's current stock value. Our valuation model uses many indicators to compare Bruker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bruker competition to find correlations between indicators driving Bruker's intrinsic value. More Info.Bruker is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bruker is roughly 4.58 . At this time, Bruker's Return On Equity is relatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Bruker by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bruker's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bruker's earnings, one of the primary drivers of an investment's value.Bruker's Earnings Breakdown by Geography
Bruker Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bruker's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bruker could also be used in its relative valuation, which is a method of valuing Bruker by comparing valuation metrics of similar companies.Bruker is currently under evaluation in operating margin category among related companies.
Bruker ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bruker's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bruker's managers, analysts, and investors.Environmental | Governance | Social |
Bruker Fundamentals
| Return On Equity | 0.3 | ||||
| Return On Asset | 0.0661 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 12.39 B | ||||
| Shares Outstanding | 145.34 M | ||||
| Shares Owned By Insiders | 33.17 % | ||||
| Shares Owned By Institutions | 77.49 % | ||||
| Number Of Shares Shorted | 4.1 M | ||||
| Price To Earning | 67.10 X | ||||
| Price To Book | 8.75 X | ||||
| Price To Sales | 4.07 X | ||||
| Revenue | 2.96 B | ||||
| Gross Profit | 1.31 B | ||||
| EBITDA | 597.2 M | ||||
| Net Income | 427.2 M | ||||
| Cash And Equivalents | 733.6 M | ||||
| Cash Per Share | 4.95 X | ||||
| Total Debt | 1.38 B | ||||
| Debt To Equity | 1.20 % | ||||
| Current Ratio | 2.55 X | ||||
| Book Value Per Share | 9.74 X | ||||
| Cash Flow From Operations | 350.1 M | ||||
| Short Ratio | 4.10 X | ||||
| Earnings Per Share | 2.73 X | ||||
| Price To Earnings To Growth | 3.64 X | ||||
| Target Price | 82.1 | ||||
| Number Of Employees | 9.71 K | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 11.23 B | ||||
| Total Asset | 4.25 B | ||||
| Retained Earnings | 2.32 B | ||||
| Working Capital | 962.1 M | ||||
| Current Asset | 1.23 B | ||||
| Current Liabilities | 554.6 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 0.36 % | ||||
| Net Asset | 4.25 B | ||||
| Last Dividend Paid | 0.2 |
About Bruker Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bruker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bruker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bruker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 400 M | 420 M | |
| Total Revenue | 3 B | 3.1 B | |
| Cost Of Revenue | 1.4 B | 737 M | |
| Stock Based Compensation To Revenue | 0.01 | 0 | |
| Sales General And Administrative To Revenue | 0.25 | 0.26 | |
| Research And Ddevelopement To Revenue | 0.1 | 0.14 | |
| Capex To Revenue | (0.04) | (0.04) | |
| Revenue Per Share | 20.25 | 21.26 | |
| Ebit Per Revenue | 0.16 | 0.17 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Bruker Piotroski F Score and Bruker Altman Z Score analysis. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Bruker Stock analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Bruker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bruker. If investors know Bruker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bruker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Dividend Share 0.2 | Earnings Share 2.73 | Revenue Per Share 20.554 | Quarterly Revenue Growth 0.053 |
The market value of Bruker is measured differently than its book value, which is the value of Bruker that is recorded on the company's balance sheet. Investors also form their own opinion of Bruker's value that differs from its market value or its book value, called intrinsic value, which is Bruker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bruker's market value can be influenced by many factors that don't directly affect Bruker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bruker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.